US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

US FDA News: FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
Read more: FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Statement by FDA Commissioner Scott Gottlieb, M.D. on efforts by the agency to address the impact of IV saline products and amino acids for injection shortages following the hurricane and update on FDA’s work in Puerto Rico
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Pharma Reviews: Distinguished Industry Leaders Engage in a Turnkey Meeting to add Fillip to India's Pre-eminent ...

The 2nd edition of the celebrated India Pharma Week, a UBM India initiative -- introduced last year to celebrate a decade of CPhI & P-MEC, UBM's flagship engagement platform, and the world's leading Pharmaceutical networking event -- witnessed one of its most significant events, the CEO Round ...
Read more: Distinguished Industry Leaders Engage in a Turnkey Meeting to add Fillip to India's Pre-eminent ...

US FDA News: FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

FDA/CMS parallel review process makes test for efficient identification of multiple targeted therapy options available to health care professionals, patients and eligible Medicare beneficiaries‎ sooner
Read more: FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

Pharma Reviews: Virat Kohli is CNN-News18 Indian of the Year 2017

As CEO of Serum Institute, he has taken the pharma company to new heights. Nearly two-thirds of world's children are vaccinated with a Serum Institute product. Serum Institute vaccines sold at a fraction of global prices his charitable foundation supports path-breaking civic initiatives in Pune. He was ...
Read more: Virat Kohli is CNN-News18 Indian of the Year 2017

Pharma Reviews: CEO round table at Indian Pharma Week

India's pharmaceutical leaders deliberated vital issues like efforts for quality compliance, make in India in pharma sector, affordable health care and Indian pharma's supremacy at the CEO Round Table organised as a part of second edition of Indian pharma week organised by UBM in Mumbai.
Read more: CEO round table at Indian Pharma Week

Pharma Reviews: Developing on the pharma success story

The Indian pharmaceutical industry has always been at the forefront of serving the nation. From a net importer of drugs in the 1950s, today, India ...
Read more: Developing on the pharma success story

Pharma Reviews: Women in Pharma: A Path-breaking Initiative to Close in on the Gender Gap in the Burgeoning ...

The 2nd edition of the celebrated India Pharma Week, a UBM India initiative ... The percentage of women executive directors in the pharmaceutical ...
Read more: Women in Pharma: A Path-breaking Initiative to Close in on the Gender Gap in the Burgeoning ...

Pharma Reviews: CNN-News18 Indian of the Year 2017 LIVE: Virat Kohli is Indian of the Year

The year 2006 saw the introduction of the CNN-News18 Indian of the Year. ... As CEO of Serum Institute, he has taken the pharma company to new ...
Read more: CNN-News18 Indian of the Year 2017 LIVE: Virat Kohli is Indian of the Year

Pharma Reviews: Government needs proactive approach to boost pharma sector: Industry

The Indian pharmaceutical industry, with current market size of USD 27.57 billion is expected to reach USD 55 billion by 2020 growing at a CAGR of ...
Read more: Government needs proactive approach to boost pharma sector: Industry

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH"

FDA Commissioner Gottlieb provides testimony before the House Committee on Energy and Commerce on the agency’s implementation of the 21st Century Cures Act
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH"

Pharma Reviews: Pharma industry leaders to come out with a white paper report to be presented to policy makers

Pharma industry leaders deliberated on issues related to domestic pharma industry with focus on affordable healthcare to come out with a white paper for the policy makers on the occasion of the CEO Round Table as part of the 2nd edition of India Pharma Week, a UBM India initiative introduced to ...
Read more: Pharma industry leaders to come out with a white paper report to be presented to policy makers

Pharma Reviews: Need to overcome challenges to ensure pharma supremacy: UBM India MD

Mudras said, “Renowned as the pharmacy hub of the world, the Indian pharma economy has been lauded for its rapid growth, with a CAGR of 17.6 per cent. As we congregated for this elite knowledge-sharing session, we confronted the Indian pharma industry at a very crucial juncture in its growth ...
Read more: Need to overcome challenges to ensure pharma supremacy: UBM India MD

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Though India ranks amongst the top four pharmaceutical markets in terms of volume of produced drugs, certain challenges continue to plague its ...
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Though India ranks amongst the top four pharmaceutical markets in terms of volume of produced drugs, certain challenges continue to plague its pharma industry, Yogesh Mudras, managing director, UBM India, said on Wednesday. India faces issues including a time-consuming approval process, ...
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Healthcare's dilemma: Balancing public needs with business sense

Even the National Pharmaceutical Pricing Authority (NPPA), India's drug pricing watchdog, jumped in to demand copies of the bills, names of the ...
Read more: Healthcare's dilemma: Balancing public needs with business sense

Pharma Reviews: Government needs proactive approach to boost pharma sector: Industry

Speaking on the occasion, Indian Pharmaceutical Alliance secretary general D G Shah said, for 'Make in India', certain standards need to be set. It needs to take the initial steps and gain the confidence of the regulators and also understand that the industry culture and behavior are inter-linked.
Read more: Government needs proactive approach to boost pharma sector: Industry

Pharma Reviews: UBM organsises 'Women in Pharma' to celebrate contribution of women in pharma industry

The 2nd edition of the India Pharma Week, a UBM India initiative -- introduced last year to celebrate a decade of CPhI & P-MEC, UBM's flagship engagement platform, and the world's leading Pharmaceutical networking event -- witnessed one of its most inspiring and scintillating initiatives, 'Women in ...
Read more: UBM organsises 'Women in Pharma' to celebrate contribution of women in pharma industry

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

... dependence on China for cheaper active pharmaceutical ingredient (API) sources, sub-optimal infrastructure, lack of funding avenues, and a shortage of highly skilled talent, among others, he said while speaking at the 2nd edition of the CEO Round Table on the sidelines of the India Pharma Week.
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Indian healthcare industry needs to focus on total health solutions rather than only sickness

New Delhi: The health food and dietary supplements market in India exists mostly as a part of large pharma and food companies. ... “The Indian healthcare industry needs to look at health as a whole rather than only sickness or illness in order to provide total health solutions to patients,” said Dr R B ...
Read more: Indian healthcare industry needs to focus on total health solutions rather than only sickness

Pharma Reviews: Nigeria new attraction for Indian pharma firms

ACCRA: As Indian pharma firms look to increase their footprints in Africa, Nigeria seems to be offering opportunities, as its pharmaceutical market is ...
Read more: Nigeria new attraction for Indian pharma firms

US FDA News: Biotin (Vitamin B7): Safety Communication - May Interfere with Lab Tests

Biotin in patient samples can cause falsely high or falsely low results, depending on the test. Incorrect test results may lead to inappropriate patient management or misdiagnosis.
Read more: Biotin (Vitamin B7): Safety Communication - May Interfere with Lab Tests

Pharma Reviews: Datwyler bolsters presence in India with advanced healthcare solutions for drug packing and ...

Datwyler, the Swiss-based leading industrial supplier that offers state-of-the-art solutions for drug packaging and medical devices announced that the expansion of its plant in Pune will be completed by end of 2017 and first samples will be supplied in July 2018. The facility underlines the company's ...
Read more: Datwyler bolsters presence in India with advanced healthcare solutions for drug packing and ...

Pharma Reviews: $23 billion fund sees more gains in costly Indian developers

“Indian pharma companies are building a strong product portfolio for post-2020. From a 12-18 months perspective, the sector looks good.” “We are seeing a turnaround for pharma? in India. For ?emerging markets, the big issue was currency. With the currency stabilizing, markets are growing ?at 15-20 ...
Read more: $23 billion fund sees more gains in costly Indian developers

Pharma Reviews: UBM India's CPhI and P-Mec underway in Mumbai

With a compounded annual growth of 17.6%, Indian pharma sector is expected to be worth 55 billion USD by 2020. In line with this, the life science ...
Read more: UBM India's CPhI and P-Mec underway in Mumbai

Pharma Reviews: $23 Billion Fund Sees More Gains in Costly Indian Developers

$23 Billion Fund Sees More Gains in Costly Indian Developers ... “Indian pharma companies are building a strong product portfolio for post-2020.
Read more: $23 Billion Fund Sees More Gains in Costly Indian Developers

Pharma Reviews: 11th edition of CPhI & P-MEC India gets underway in Mumbai

Speaking at the inauguration of CPhI & P-MEC India, Mr Mudras of UBM India said, "India is among the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the ...
Read more: 11th edition of CPhI & P-MEC India gets underway in Mumbai

Product Recall Alerts: Possible Fungal Contamination Prompts Recall of Diabetes Drug Riomet

The Food and Drug Administration (FDA) has posted a recall notification for two ... Use of contaminated product could result in infection, especially for ...
Read more: Possible Fungal Contamination Prompts Recall of Diabetes Drug Riomet

Pharma Reviews: Drug regulator to make 'stability testing' a must for all medicines sold in India

Pharma companies will now have to subject their medicines to quality tests to make sure that they do not lose their potency and the expiry dates ...
Read more: Drug regulator to make 'stability testing' a must for all medicines sold in India

Pharma Reviews: Check IPO pricing

Few listed brick-and-mortar companies are making project investments. India's information technology (IT) firms and pharma companies are under ...
Read more: Check IPO pricing

Pharma Reviews: Landmark Celebration of UBM India's 11th Edition of CPhI & P-MEC India Gets Underway Today

Originating from CPhI Worldwide, the CPhI & P-MEC India was first introduced in 2006. Today, it has become South Asia's leading pharma meeting place, covering every step of the supply chain, from drug discovery to finished dosage. CPhI India is an industry platform encompassing CROs, CMOs and ...
Read more: Landmark Celebration of UBM India's 11th Edition of CPhI & P-MEC India Gets Underway Today

US FDA News: Riomet (Metformin Hydrochloride Oral Solution): Recall - Microbial Contamination

Use of the affected product potentially could result in a risk of infection, especially in an immunocompromised patient.
Read more: Riomet (Metformin Hydrochloride Oral Solution): Recall - Microbial Contamination

Pharma Reviews: Indian Pharma run rate slows down in Q2 2018

Majority of Indian pharmaceutical companies have reported disappointing results in Q2 of FY 2018 compared to the same period last year. Financial analysts believe the sharp drop in pharma margins are due to regulatory and pricing challenges in the U.S market in addition to the changes created by ...
Read more: Indian Pharma run rate slows down in Q2 2018

Pharma Reviews: Uzbekistan invites Indian pharma industries to come and Make in Uzbek

New Delhi, Nov 27 (KNN) In a bid to attract investments from India, Uzbekistan urged the Indian pharma industry comprising of a fair share of Micro, ...
Read more: Uzbekistan invites Indian pharma industries to come and Make in Uzbek

Pharma Reviews: Indian pharma plans new set-up in Cambodia

India-based pharmaceutical company, VTSIX Group, will soon be setting up a factory in Cambodia in early 2018 after signing a land lease agreement ...
Read more: Indian pharma plans new set-up in Cambodia

Pharma Reviews: Stocks To Watch: Ashok Leyland, Hindustan Unilever, Sun Pharma

Indian equity benchmarks closed little changed after fluctuating intraday on ... Sun Pharmaceutical Industries to recall Riomet drug due to microbial ...
Read more: Stocks To Watch: Ashok Leyland, Hindustan Unilever, Sun Pharma

Pharma Jobs: Area Sales Manager

Company: Kuresys Labs Private Limited
Qualification: Any graduate
Experience: 2 to 5
location: Delhi, Noida
Ref: 21569069
Summary: Looking for Area Sales Manager Pharma for Delhi, Greater Noida & Noida Region Salary Range : INR 3,00,000 - 5,50,000 P.A

Read more: Area Sales Manager

Pharma Reviews: SCHOTT KAISHA to showcase innovative range of packaging solutions at CPhI India 2017

The Indian pharma packaging leader will also be showcasing its enhanced portfolio of ready-to-use (RTU) packaging, which now includes nested cartridges. As the range of nested solutions has made pharmaceutical manufacturing lines more efficient, the new system will give pharma manufacturers a ...
Read more: SCHOTT KAISHA to showcase innovative range of packaging solutions at CPhI India 2017

Pharma Reviews: Sun Pharma recalls two lots of diabetes drug due to microbial contamination

New Delhi: Indian drug major Sun Pharma's subsidiary in the US is ... Sun Pharmaceutical Industries, Inc (SPII), Sun Pharma's wholly owned ...
Read more: Sun Pharma recalls two lots of diabetes drug due to microbial contamination

Pharma Reviews: WHO to hold consultation on Survey of Indian Pharma Enterprises for Meeting National & Global ...

World Health Organization (WHO) is planning to analyze the performances of Indian pharmaceutical industry and the international laws for trade and ...
Read more: WHO to hold consultation on Survey of Indian Pharma Enterprises for Meeting National & Global ...

Pharma Reviews: Uzbekistan invites Indian cos to invest in its 7 new free economic zones for pharma

Uzbekistan, which is a leading country from the Commonwealth Independent states (CIS) region, has invited Indian pharmaceutical manufacturers to ...
Read more: Uzbekistan invites Indian cos to invest in its 7 new free economic zones for pharma

Pharma Reviews: Brinton Pharma eyes second round of funding to finance growth

Brinton Pharma eyes second round of funding to finance growth ... A report by Deloitte Touche Tohmatsu India indicates the size of the industry will reach USD 280 billion by 2020 from the present USD 160 billion. PTI AP BEN BEN . This is unedited, unformatted feed from the Press Trust of India wire.
Read more: Brinton Pharma eyes second round of funding to finance growth

Pharma Reviews: Everstone Group acquires Malaysian medical products company Chemopharm

The Everstone Group has significant experience in the healthcare sector. Similar to Everlife, Everstone has also invested in Ascent, the leading Indian pharma distribution platform, which has scaled rapidly under Everstone's ownership. Other Everstone investments in healthcare are Rubicon, ...
Read more: Everstone Group acquires Malaysian medical products company Chemopharm

Pharma Reviews: Systech, NKP Pharma ink agreement to deliver pharmaceutical serialization & traceability solutions ...

"Regionally specific serialization regulations are rapidly rolling out and Indian pharma must meet them to ensure full compliance in order to continue serving a global market," said Harry Saint-Preux, director - Global Alliances & Channels. "Our partnership with NKP allows for simplified regulatory ...
Read more: Systech, NKP Pharma ink agreement to deliver pharmaceutical serialization & traceability solutions ...

Pharma Reviews: Leading Indian drug makers evince interest in setting up units in RAKEZ, UAE

Around 8-10 leading pharmaceutical companies from India have evinced interest in setting up their units and facilities in Ras Al Khaimah Economic ...
Read more: Leading Indian drug makers evince interest in setting up units in RAKEZ, UAE

Pharma Reviews: Govt plans tweaks in law to make firms liable for defective devices, drugs

The Central Drug Standards Control Organization (CDSCO), the national regulatory body for Indian pharmaceutical and medical device makers, has ...
Read more: Govt plans tweaks in law to make firms liable for defective devices, drugs

Pharma Reviews: Innovations to Scale-up Healthcare Industry

A good example of which is many Indian Pharma companies are selling their drugs in the western world at much economical rates and with an ...
Read more: Innovations to Scale-up Healthcare Industry

US FDA News: FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients

FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
Read more: FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients

Pharma Reviews: Thermo Fisher calls for multi-pronged approach to tackle menace of counterfeit products

According to the Indian Journal of Pharmaceutical Sciences' research study that ... Thermo Fisher Scientific, with its in-depth pharmaceutical industry ...
Read more: Thermo Fisher calls for multi-pronged approach to tackle menace of counterfeit products

Pharma Reviews: Systech International and NKP Pharma Expand Presence in India to Deliver Pharmaceutical ...

The accord allows the two companies to provide software/hardware solutions to the Indian pharmaceutical industry that meet serialization and ...
Read more: Systech International and NKP Pharma Expand Presence in India to Deliver Pharmaceutical ...

Pharma Reviews: Pharma stocks outperform, Nifty ends the session marginally higher

Pharma stocks outperform, Nifty ends the session marginally higher ... Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be ... Support levels for the market inched higher with 10300PE witnessing heavy ...
Read more: Pharma stocks outperform, Nifty ends the session marginally higher

US FDA News: FDA approves first two-drug regimen for certain patients with HIV

FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.
Read more: FDA approves first two-drug regimen for certain patients with HIV

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

FDA Commissioner on steps to promote development of generic versions of opioids formulated to deter abuse
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

US FDA News: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems

Anyone who is currently taking Limbrel may be at risk for developing symptoms associated with drug-induced liver injury and/or hypersensitivity pneumonitis. Posted 11/21/2017
Read more: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems

Pharma Reviews: Nadda for more investment, players in medical devices sector

The Union health minister said India is deeply committed, both nationally and globally, for achieving all public health goals and was also focusing on ... Highlighting the importance of transparency between regulatory authorities and pharma sector, he said coordination between national regulatory ...
Read more: Nadda for more investment, players in medical devices sector

Pharma Reviews: The 'India Pharma Week' Returns With a Week Full of Avant-garde Events Alongside CPhI and P ...

An epitome of India's strength in the pharma industry, the expo has consistently grown to serve as an exclusive congregation of key global players across the pharmaceutical sector. Over the past few years, India is seen as a potential market for global pharmaceutical manufacturers and is now ready to ...
Read more: The 'India Pharma Week' Returns With a Week Full of Avant-garde Events Alongside CPhI and P ...

Pharma Reviews: Pharma firms tide over GST impact

Pharma industry players say that during April to June period, several pharma ... "The Indian pharmaceutical market's growth had eased to around 3%, ...
Read more: Pharma firms tide over GST impact

Pharma Reviews: Banning combination drugs: A high-stakes case in point

Except the problem in India is that the pharmaceutical industry has turned to FDCs to escape price control. Back in the day when Drug Price Control Orders established prices of drugs with single ingredients, the pharmaceutical industry decided to combine different drugs into a FDC, thereby creating a ...
Read more: Banning combination drugs: A high-stakes case in point

Pharma Reviews: Adverse observations on domestic facilities: Tackling the USFDA regulatory heat

The Indian Express has reviewed the detailed responses sent by two Indian drug manufacturers, Strides Shasun for its Bengaluru (Anekal Taluk) facility and Cadila Healthcare for its Matoda (Sanand) facility on the USFDA observations, following which the US regulator has accorded clearances to these ...
Read more: Adverse observations on domestic facilities: Tackling the USFDA regulatory heat

Pharma Reviews: CPhI India 2017 to take place at two venues in Mumbai

CPhI India 2017, India's largest and leading pharmaceutical exhibition will be taking place at two venues in Mumbai - the Bombay Convention and Exhibition Centre (BCEC) and the MMRDA Grounds, Bandra Kurla Complex (BKC).While BCEC will host it between November 28 and 30, BKC will kick off ...
Read more: CPhI India 2017 to take place at two venues in Mumbai

Pharma Reviews: We expect big numbers to kick in from FY20-FY21: Kiran Mazumdar Shaw, Biocon

The signalling should be that Biocon has complied with all USFDA problems and unlike other Indian pharma companies, decks are cleared for Biocon ...
Read more: We expect big numbers to kick in from FY20-FY21: Kiran Mazumdar Shaw, Biocon

Pharma Reviews: Chinese investors keen on infra projects in India

Chinese investors keen on infra projects in India ... Agriculture and Food Processing Sector and Bio-Technology and Pharma Industry; Infrastructure, ...
Read more: Chinese investors keen on infra projects in India

Pharma Reviews: The Red In That Green

Since that 2013 judgement, the US and UK have tried to get Indian laws diluted. “MNCs perceived a threat from the steady growth of Indian pharma companies before 2005,” says James. “So, several attempts were made to tweak laws in their favour.” The US even had India put on the “priority watchlist” ...
Read more: The Red In That Green

US FDA News: FDA approves first telehealth option to program cochlear implants remotely

FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Read more: FDA approves first telehealth option to program cochlear implants remotely

Pharma Reviews: Eris Life to acquire Strides' India business for Rs 500 crore

MUMBAI: Bengaluru-based drug maker Strides Shasun has agreed to sell its domestic branded formulations business to Ahmedabad-based Eris Lifesciences for Rs 500 crore, joining a select league of Indian pharmaceuticals firms exiting domestic market to focus on more lucrative international ...
Read more: Eris Life to acquire Strides' India business for Rs 500 crore

US FDA News: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

The use of this product in patients with uncontrolled diarrhea due to chronic medical conditions may predispose the patient to toxicity from either the diphenoxylate or atropine components. Posted 11/17/2017
Read more: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Pharma Reviews: Gujarat elections: Pharma sector eyes GST boost, thanks BJP govt for infra push

“Brand Gujarat has been in high demand all over India, specially for the pharma sector, given the fact that Gujarat produces the highest quality of ...
Read more: Gujarat elections: Pharma sector eyes GST boost, thanks BJP govt for infra push

Pharma Reviews: Two hundred pharma personnel in TN & Pondicherry were trained by IPC in setting up PV system

... pharmacovigilance (PV) system to become a mandatory in-house mechanism for all pharmaceutical manufacturing units, the Indian Pharmacopoeia ...
Read more: Two hundred pharma personnel in TN & Pondicherry were trained by IPC in setting up PV system

US FDA News: FDA expands approval of Sutent to reduce the risk of kidney cancer returning

FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.
Read more: FDA expands approval of Sutent to reduce the risk of kidney cancer returning

US FDA News: FDA approves new treatment to prevent bleeding in certain patients with hemophilia A

FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.
Read more: FDA approves new treatment to prevent bleeding in certain patients with hemophilia A

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health

Commissioner statement on FDA’s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health

US FDA News: FDA announces comprehensive regenerative medicine policy framework

FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.
Read more: FDA announces comprehensive regenerative medicine policy framework

Pharma Reviews: To pay back ONGC Videsh, Venezuela's PDUSA offers oil in lieu of cash

India's exports to Venezuela fell from $258 million in 2014-15 to just $62.22 million in the last financial year, mostly on account of pharmaceutical ...
Read more: To pay back ONGC Videsh, Venezuela's PDUSA offers oil in lieu of cash

Pharma Reviews: Pharma growth to pick up in 2nd half

Expectations of a gradual reduction in pricing pressure in the US market were belied as Indian pharmaceutical companies reported another quarter of ...
Read more: Pharma growth to pick up in 2nd half

US FDA News: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

Newly authorized test detects genetic cancer mutations in 468 unique genes
Read more: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

US FDA News: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall - Presence Of Particulate Matter

Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences.
Read more: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall - Presence Of Particulate Matter

US FDA News: FDA approves treatment for rare genetic enzyme disorder

FDA approves treatment for rare genetic enzyme disorder
Read more: FDA approves treatment for rare genetic enzyme disorder

Pharma Reviews: Imports To Fuel India's Active Pharmaceutical Ingredients' Requirements

India Ratings and Research expects India to remain dependent on imports for its Active Pharmaceutical Ingredients (API) requirements at least in the ...
Read more: Imports To Fuel India's Active Pharmaceutical Ingredients' Requirements

US FDA News: Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

Preliminary safety trial results in over 6,000 patients with gout being evaluated.
Read more: Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

US FDA News: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal
Read more: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

US FDA News: FDA warns about illegal use of injectable silicone for body contouring and associated health risks

FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks
Read more: FDA warns about illegal use of injectable silicone for body contouring and associated health risks

US FDA News: Injectable Silicone for Body Contouring and Enhancement: FDA Safety Communication - FDA Warns Against Use

Silicone, when injected into areas with many blood vessels, can travel to other parts of the body and block blood vessels in the lungs, heart, or brain. This can result in permanent damage to those tissues and lead to stroke or death.
Read more: Injectable Silicone for Body Contouring and Enhancement: FDA Safety Communication - FDA Warns Against Use

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom

A botanical substance known as kratom has raised significant concerns given its increasing prevalence and potential safety risks. The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom

Pharma Reviews: Call for 'complete' overhaul of India's CSIR

CSIR is the country's largest public sector research and development ... to development of Indian pharma and chemical companies during 1980s and ...
Read more: Call for 'complete' overhaul of India's CSIR

Pharma Reviews: Roche appoints Lara Bezerra as Roche Pharma India MD

Roche Pharmaceutical Asia Pacific Region head Christiane Hamacher said: "We are delighted to have Lara Bezerra join Roche India from Venezuela.
Read more: Roche appoints Lara Bezerra as Roche Pharma India MD

Pharma Reviews: Assam strides towards flourishing economic and social advancement

The Indian Pharmaceutical Market which has a global reputation of selling high quality, low cost drugs, can leverage this by welcoming more and ...
Read more: Assam strides towards flourishing economic and social advancement

Pharma Reviews: Indian Pharmaceutical Alliance pitches for exception of GST on expired and damaged drugs

The Indian Pharmaceutical Alliance has been pitching with the government to exempt Goods and Services Tax (GST) on drugs that are expired or ...
Read more: Indian Pharmaceutical Alliance pitches for exception of GST on expired and damaged drugs

US FDA News: FDA approves pill with sensor that digitally tracks if patients have ingested their medication

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
Read more: FDA approves pill with sensor that digitally tracks if patients have ingested their medication

Pharma Reviews: Sale of diabetes drug rise from 151 crore to 842 crore in 9 years: Study

Indiscriminate use of newer oral drugs and insulin is often seen in India and here, ... India has to take several stringent measures to ensure that there is a ... were tracked every month from pharmaceutical stockists and distributors.
Read more: Sale of diabetes drug rise from 151 crore to 842 crore in 9 years: Study

Pharma Reviews: Gujarat set to give China stiff competition in hormone APIs

Ahmedabad: Gujarat could potentially breach China a virtual monopoly in catering to India's $400 million hormonal active pharmaceutical ingredient ...
Read more: Gujarat set to give China stiff competition in hormone APIs

Pharma Reviews: Rakesh Jhunjhunwala says make at least this much return in stock market or go home

I see no way in which Indian equities will give anything below 15%.” ... Last month during Diwali, Rakesh Jhunjhunwala said that pharma industry is ...
Read more: Rakesh Jhunjhunwala says make at least this much return in stock market or go home

Pharma Reviews: Fresh salvo in the turf battle between innovator & generic drug makers

Some of the senior officials and business leaders from the Indian pharmaceutical companies also complained about this though none of them wanted ...
Read more: Fresh salvo in the turf battle between innovator & generic drug makers

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Mumbai
Ref: 21513000
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Pune
Ref: 21513005
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Bengaluru / Bangalore
Ref: 21513008
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher ....
Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Biotechnology walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Bengaluru / Bangalore
Ref: 21513051
Summary: Biotechnology ,Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Biotechnology walk in Interview 13 November 2017 to 25 November 2017

Pharma Reviews: Putting the spotlight back on domestic consolidation

The Indian pharmaceutical space has long been waiting for consolidation, Torrent Pharmaceuticals Chairman Samir Mehta had told BusinessLine's ...
Read more: Putting the spotlight back on domestic consolidation

Pharma Reviews: UBM India Brings in the 12th Edition of Food Ingredients India & Health Ingredients in Mumbai

UBM has a strong foothold in key industry segments like Food, Pharma and Cosmetics. Packaging being the most integral part of these industries, the ...
Read more: UBM India Brings in the 12th Edition of Food Ingredients India & Health Ingredients in Mumbai

US FDA News: Compounded Glutamine, Arginine, and Carnitine Product for Injection by United Pharmacy: Compounding Risk Alert - FDA Investigates Two Adverse Events

Parenteral drugs, including compounded injectable drugs, with a high pH may lead to skin damage or other unintended health consequences.
Read more: Compounded Glutamine, Arginine, and Carnitine Product for Injection by United Pharmacy: Compounding Risk Alert - FDA Investigates Two Adverse Events

Pharma Reviews: Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics market

NEW DELHI: Indian pharmaceutical firm Morepen Laboratories Ltd, listed on the Bombay Stock Exchange, has inked an exclusive agreement to ...
Read more: Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics market

Pharma Reviews: Companies cut hiring costs with in-house cells

Sun Pharmaceutical Industries (Sun Pharma), Philips India and Johnson & Johnson (J&J) have already built in-house capabilities to hire executives.
Read more: Companies cut hiring costs with in-house cells

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

To further streamline the submission and review process for shared system REMS (for any REMS that includes more than one medication), today the FDA is releasing a draft guidance for industry, Use of a Drug Master File for Shared System REMS Submissions, that describes how applicants can submit collective sets of files to the FDA that represent all participating firms.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

Pharma Reviews: Gujarat takes lead to resolve pending cases on food adulteration

Deepnath Roy Chowdhury, National President, Indian Drug Manufacturers' Association (IDMA), pointed out some regulatory challenges in the current ...
Read more: Gujarat takes lead to resolve pending cases on food adulteration

Pharma Reviews: Pharma sector raises demand of GST exemption on expired and damaged medicines

Indian Pharmaceutical Alliance (IPA) in a statement said that the exemption of GST on expired and damaged stock of medicines is vital to prevent ...
Read more: Pharma sector raises demand of GST exemption on expired and damaged medicines

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on a practical approach to ensuring timely implementation of FDA’s menu labeling rule

FDA menu labeling guidance
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on a practical approach to ensuring timely implementation of FDA’s menu labeling rule

Pharma Reviews: Rising crude prices behind markets taking breather: Pankaj Tibrewal, Kotak Mutual Fund

Talking to ET Now, Pankaj Tibrewal , SVP & Fund Manager-Equities, Kotak Mutual Fund , says the tailwinds which we enjoyed on the macro for the ...
Read more: Rising crude prices behind markets taking breather: Pankaj Tibrewal, Kotak Mutual Fund

Pharma Reviews: Will continue to pursue inorganic growth in India & US: Torrent Pharma

Mehta said that Torrent will become fifth largest company in India, with ... According to him, Indian pharma market is large and therefore, he expects ...
Read more: Will continue to pursue inorganic growth in India & US: Torrent Pharma

Pharma Reviews: Pharma cos need to find chemical attractants to fight menace of mosquito-borne diseases. Dr Biju ...

In the wake of increasing number of mosquito borne diseases and high mortality rates happening every year, the pharmaceutical industry in India ...
Read more: Pharma cos need to find chemical attractants to fight menace of mosquito-borne diseases. Dr Biju ...

US FDA News: FDA clears common blood cell count test that offers faster results for patients and providers

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians’ offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.
Read more: FDA clears common blood cell count test that offers faster results for patients and providers

Pharma Reviews: Indian pharma majors under investigation for multistate antitrust scheme

The fate of seven Indian pharmaceutical companies functioning in the US stays hanging as Connecticut Attorney General George Jepsen along with ...
Read more: Indian pharma majors under investigation for multistate antitrust scheme

Pharma Reviews: GST on expired and damaged stocks costs pharma Rs 500 crore a year

Why should there be the Goods and Services Tax (GST) on materials that cannot be sold? That is the question, the Indian pharmaceutical industry, ...
Read more: GST on expired and damaged stocks costs pharma Rs 500 crore a year

Pharma Reviews: ET Analysis: With Unichem Buy, Torrent's new M&A star in pharma

However, what the deal underscores is the rise of Ahmedabadbased Torrent Pharma as another Indian pharma firm being successful at its M&A game ...
Read more: ET Analysis: With Unichem Buy, Torrent's new M&A star in pharma

US FDA News: FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

FDA expands approval of Zelboraf (vemurafenib) to include treatment of certain adult patients with Erdheim-Chester Disease, a rare blood cancer. This is the first FDA-approved treatment for ECD.
Read more: FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

US FDA News: Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health: Voluntary Field Action - Incorrect Artwork on Packaging

If the user incorrectly places the defibrillation electrodes, it may result in ineffective energy delivery to the patient and serious injury or death.
Read more: Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health: Voluntary Field Action - Incorrect Artwork on Packaging

US FDA News: Ridge Properties DBA Pain Relief Naturally Products: Recall - Manufacturing Concerns at the Facility

Risk of decreased quality and consistency (i.e., the safety, identity, strength, quality and purity)
Read more: Ridge Properties DBA Pain Relief Naturally Products: Recall - Manufacturing Concerns at the Facility

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks

Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks

Pharma Jobs: Urgent opening for General practitioners and family physicians in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21475513
Summary: General practitioners and family physicians diagnose and treat the diseases, physiological disorders and injuries of patients. They provide primary contact and continuous care....
Read more: Urgent opening for General practitioners and family physicians in CANADA

Pharma Jobs: Urgent opening for Medical laboratory technicians and pathologists' assistants in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21475746
Summary: Medical laboratory technicians conduct routine medical laboratory tests and set up, clean and maintain medical laboratory equipment. They are employed in medical laboratories in....
Read more: Urgent opening for Medical laboratory technicians and pathologists' assistants in CANADA

Pharma Jobs: Urgent opening for Respiratory therapists, clinical perfusionists and cardiopulmonary tech in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21475803
Summary: Respiratory therapists assist physicians in the diagnosis, treatment and care of patients with respiratory and cardiopulmonary disorders. Clinical perfusionists provide technical....
Read more: Urgent opening for Respiratory therapists, clinical perfusionists and cardiopulmonary tech in CANADA

Pharma Jobs: Urgent opening for Pharmacists in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21476404
Summary: Community pharmacists and hospital pharmacists compound and dispense prescribed pharmaceuticals and provide consultative services to both clients and health care providers. They....
Read more: Urgent opening for Pharmacists in CANADA

Pharma Jobs: Urgent opening for Biologists and related scientists in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21477200
Summary: Biologists and related scientists conduct basic and applied research to extend knowledge of living organisms, to manage natural resources, and to develop new practices and....
Read more: Urgent opening for Biologists and related scientists in CANADA

Pharma Reviews: Khel Kabaddi! Why The Sport Of India's Masses Is Going To The Next Level

Why The Sport Of India's Masses Is Going To The Next Level .... Unilazer Sports, the company that owns Mumbai-based pro-Kabaddi team U Mumba.
Read more: Khel Kabaddi! Why The Sport Of India's Masses Is Going To The Next Level

Pharma Reviews: Unichem's Shareholders Will Be Rewarded Adequately, Says Chairman And MD

Even today, I always say that India is a growing pharmaceutical market. We were very well positioned as far this was concerned. The question is ...
Read more: Unichem's Shareholders Will Be Rewarded Adequately, Says Chairman And MD

Pharma Reviews: Affordable Housing Leads A Selective Turnaround In Indian Real Estate

The real estate industry has transitioned to a more structured environment ... Mumbai-based Unichem, ranked 24th in the Indian pharma market, has ...
Read more: Affordable Housing Leads A Selective Turnaround In Indian Real Estate

Pharma Reviews: This conventional businessman is set for second innings

A modest man with modest ambition but a passion to run business ethically, is the remark most members of the Indian pharma industry that ET spoke ...
Read more: This conventional businessman is set for second innings

Pharma Reviews: Torrent to acquire Unichem's India, Nepal business for ₹3600 cr

Ahmedabad-based Torrent Pharmaceuticals Ltd has said that it will acquire the India and Nepal businesses of Mumbai-based Unichem Laboratories ...
Read more: Torrent to acquire Unichem's India, Nepal business for ₹3600 cr

Pharma Reviews: Torrent Pharma to acquire India biz of Unichem for Rs 3600 crore

With this deal, Torrent Pharma will enter the list of top pharma firms in the Indian Pharma market (IPM) and will be ranked at number five in the IMS, the ...
Read more: Torrent Pharma to acquire India biz of Unichem for Rs 3600 crore

Pharma Reviews: Torrent Pharma acquires India biz of Unichem Lab for Rs. 3600 cr

Taking a lead in the consolidation of India's pharma sector, Ahmedabad-based Torrent Pharmaceuticals Ltd has said that it would acquire the India ...
Read more: Torrent Pharma acquires India biz of Unichem Lab for Rs. 3600 cr

Pharma Reviews: Torrent Pharma to acquire India biz of Unichem for Rs 3600 cr

New Delhi, Nov 3 (PTI) In a major consolidation move in the domestic pharma sector, drug firm Torrent Pharmaceuticals today said it will acquire the ...
Read more: Torrent Pharma to acquire India biz of Unichem for Rs 3600 cr

Pharma Reviews: Torrent Pharma to buy Unichem Labs' India business for $558 million

Torrent Pharmaceuticals said on Friday it would buy more than 120 brands of Unichem Laboratories in India and Nepal and its manufacturing plant at ...
Read more: Torrent Pharma to buy Unichem Labs' India business for $558 million

Pharma Reviews: Answers to Moneycontrol Ultimate Business Quiz #1

Answer: SUN Pharma. Dilip Shanghvi, founder of Sun Pharmaceutical Industries, India's most valuable drug company, and is the country's ...
Read more: Answers to Moneycontrol Ultimate Business Quiz #1

Pharma Reviews: Price-fixing allegations, a new worry to deal with for some leading Indian pharma companies in the ...

At a time when most leading Indian pharmaceutical companies complain about a combination of factors hurting them in the US, including price erosion ...
Read more: Price-fixing allegations, a new worry to deal with for some leading Indian pharma companies in the ...

Pharma Reviews: US slaps price fixing charges on Sun Pharma, Reddy's Labs, Glenmark, others in new list

... undermining competition in the country's generic pharmaceutical industry. ... a new list of firms — including a clutch of Indian ones — and medicines.
Read more: US slaps price fixing charges on Sun Pharma, Reddy's Labs, Glenmark, others in new list

Pharma Reviews: US may widen probe to 18 major Indian pharma firms

In 2015, generic drug sales in the United States were estimated at $74.5 billion, and the generic pharmaceutical industry accounts for approximately ...
Read more: US may widen probe to 18 major Indian pharma firms

Pharma Reviews: Pharma stocks rise despite price fixing charges

The Nifty pharma index moved up sharply today, in what was a tepid trading day. The gains came as a surprise as top Indian companies faced new ...
Read more: Pharma stocks rise despite price fixing charges

Pharma Reviews: Torrent may announce Unichem's domestic business buy today

MUMBAI: India's oldest drug maker Unichem has finally found a suitable buyer ... Unichem promoted by pharma industry veteran Prakash Amrut Mody ...
Read more: Torrent may announce Unichem's domestic business buy today

Pharma Reviews: Dr Reddy's Laboratories, other drug cos in price fixing case

Hyderabad: Several Indian pharma companies are under check over drug price rigging as the latest lawsuit, brought by the attorneys general of 45 ...
Read more: Dr Reddy's Laboratories, other drug cos in price fixing case

Pharma Reviews: Deepak Fertilisers Q2 PAT up 70% at Rs 47.21 crore

The Indian pharma industry, which is slated to grow at 15 per cent against global growth of 5 percent, will boost the solvents consumption, especially ...
Read more: Deepak Fertilisers Q2 PAT up 70% at Rs 47.21 crore

Pharma Reviews: Major US lawsuit accuses generic drug makers of price-fixing

A large group of US states has accused as many as 18 key players in the generic drug industry – several of them based in India - of a broad ...
Read more: Major US lawsuit accuses generic drug makers of price-fixing

Pharma Reviews: Sun Pharma, Dr Reddy's, Zydus face price fixing probe in US

Sun Pharma, Dr Reddy's, Zydus face price fixing probe in US ... A large group of US states accused key players in the generic drug industry of a broad ... Satish Mehta, CEO and managing director of India's Emcure Pharmaceuticals.
Read more: Sun Pharma, Dr Reddy's, Zydus face price fixing probe in US

Pharma Reviews: Inside track on why US states allege drug price-fixing conspiracy by Indian pharma cos

Companies accused of deliberately keeping drug prices high include Dr Reddy's Laboratories (DRL), Glenmark Pharmaceuticals, Sun Pharmaceutical ...
Read more: Inside track on why US states allege drug price-fixing conspiracy by Indian pharma cos

Pharma Reviews: Dr Reddy's, Sun Pharma and 3 other Indian generic drugmakers sued over US price-fixing ...

Soon after the charges, shares of the Indian drug companies tumbled on Wednesday. Dr Reddy's shares fell 2.9 percent to close at Rs 2,360.90 and ...
Read more: Dr Reddy's, Sun Pharma and 3 other Indian generic drugmakers sued over US price-fixing ...

Pharma Reviews: US probe into price-fixing hits Indian pharma majors

US probe into price-fixing hits Indian pharma majors ... "The generic drug market was conceived as a way to help bring down the cost of prescription ...
Read more: US probe into price-fixing hits Indian pharma majors

Pharma Reviews: Four pharma firms face US price-fixing charge

As many as four Indian drugmakers are facing allegations of a huge price-fixing conspiracy in the US aimed at keeping prices of generic drugs ...
Read more: Four pharma firms face US price-fixing charge

Pharma Reviews: Intas closing in on Mallinckrodt's US generics business

A successful transaction will give Intas — the largest privately held pharmaceutical company in India with an annual turnover of over $1 billion and a ...
Read more: Intas closing in on Mallinckrodt's US generics business

Pharma Reviews: US states sue 5 Indian generic drug makers over price cartelisation

MUMBAI: At least five Indian companies are among 12 generic drug manufacturers named in a new lawsuit over alleged price cartelisation in the US, ...
Read more: US states sue 5 Indian generic drug makers over price cartelisation

Pharma Reviews: US generic drug price-fixing conspiracy jolts Indian pharma companies

Mumbai: The global generic drugs industry, with several Indian pharma companies at its core, was jolted on Wednesday by allegations of a vast ...
Read more: US generic drug price-fixing conspiracy jolts Indian pharma companies

Pharma Jobs: Pharma Pharmacist walk in Interview 1 november 2017 to 11 november 2017

Company: Ace Group
Experience: 0 to 5
location: Bengaluru / Bangalore
Ref: 21465947
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills ....
Read more: Pharma Pharmacist walk in Interview 1 november 2017 to 11 november 2017

Pharma Jobs: Analytical Scientist (Pharmaceutical)

Company: Bright Future Pharmaceutical Laboratories Limited
Qualification: B.Pharm, M.Pharm, Mphil, PhD
Experience: 5 to 15
location: Hongkong
Ref: 21466082
Summary: Provide technical guidance for the analytical development of drug substance and drug products.

Read more: Analytical Scientist (Pharmaceutical)

Pharma Jobs: Wanted Medical Coding Freshers in Chennai

Company: Achievers Spot
Qualification: BDS, B.E/B.Tech, BAMS, BHMS, B.Pharm, B.Sc, M.E/M.Tech/MS, M.Pharm, Mphil, M.Sc
Experience: 0 to 0
Salary: 1.80 to 2.30
location: Chennai, Nellore
Ref: 21466211
Summary: Wanted Any Life Science, Paramedical, Medical....
Read more: Wanted Medical Coding Freshers in Chennai

Pharma Jobs: Physiotherapy/Nursing/Pharmacy Graduates Wanted For Medical Coding in Chennai

Company: Achievers Spot
Qualification: BDS, B.E/B.Tech, BAMS, BHMS, B.Pharm, B.Sc, M.E/M.Tech/MS, M.Pharm, Mphil, M.Sc
Experience: 0 to 0
Salary: 2.80 to 4.30
location: Chennai, Hyderabad / Secunderabad
Ref: 21466236
Summary: Medical Coding is the process of....
Read more: Physiotherapy/Nursing/Pharmacy Graduates Wanted For Medical Coding in Chennai

US FDA News: FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer

FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer
Read more: FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer

US FDA News: FDA reaches agreement with automatic external defibrillator manufacturer over quality control issues

FDA reaches agreement with automatic external defibrillator manufacturer over quality control issues
Read more: FDA reaches agreement with automatic external defibrillator manufacturer over quality control issues